Bain Capital Life Sciences Investors, LLC Cabaletta Bio, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $333 Million
- Q2 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 9,677,125 shares of CABA stock, worth $12.9 Million. This represents 4.41% of its overall portfolio holdings.
Number of Shares
9,677,125
Previous 2,760,888
250.51%
Holding current value
$12.9 Million
Previous $3.84 Million
283.35%
% of portfolio
4.41%
Previous 1.29%
Shares
5 transactions
Others Institutions Holding CABA
# of Institutions
93Shares Held
77MCall Options Held
406KPut Options Held
90.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$11.7 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$9.04 Million0.01% of portfolio
-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$6.65 Million0.77% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.8MShares$6.38 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...